Comparing Efficacy of Microwave Vs Embolization Treatment for Adenomyosis

Launched by KAROLINSKA INSTITUTET · Dec 20, 2019

Keywords

ClinConnect Summary

This clinical trial is studying two different treatments for a condition called adenomyosis, which can cause painful symptoms and heavy bleeding in women. The researchers want to find out whether a common procedure called uterine artery embolization (UAE) or a newer technique called microwave ablation is more effective in improving symptoms. Both treatments are minimally invasive, meaning they involve less risk and recovery time compared to traditional surgery.

Women aged 30 to 55 who are experiencing symptoms of adenomyosis may be eligible to participate in this study. To join, women must be healthy, premenopausal, and have been diagnosed with adenomyosis using ultrasound or MRI. Participants will answer questionnaires to help the researchers assess how well each treatment works. This trial is currently recruiting, so if you or someone you know fits the criteria, it might be a good opportunity to consider for managing adenomyosis symptoms.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Healthy women aged 30-55 with symptomatic adenomyosis
• • Premenopausal
• • Adenomyosis diagnosted by TVUS
• • Willing to comply with protocol
• Exclusion Criteria:
• • Body Mass Index \>35
• • Treatment with anticoagulant/bleeding disorder
• • Contraindication for UAE or general anesthesia